|
Market Closed -
NYSE
02:30:02 14/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 14.74 USD | +0.07% |
|
-1.14% | +4.99% |
| 11/11 | Aspen Pharmacare wins approval for generic semaglutide in Brazil, South Africa | RE |
| 10/11 | Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading | MT |
| Market Cap | 1,14700Cr 1.22TCr 1.1TCr 1.02TCr 920.08Cr 1.73TCr 1.8TCr 12TCr 4.86TCr 61TCr 4.57TCr 4.47TCr 1,94500Cr | P/E 2027 * |
31.3x | P/E 2028 * | 23.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1,11700Cr 1.18TCr 1.07TCr 992.78Cr 895.74Cr 1.69TCr 1.75TCr 12TCr 4.73TCr 60TCr 4.44TCr 4.35TCr 1,89400Cr | EV / Sales 2027 * |
3.18x | EV / Sales 2028 * | 2.79x |
| Free-Float |
68.54% | Yield 2027 * |
0.54% | Yield 2028 * | 0.61% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| RDY | Delayed | |
| RDY | Real-time | ||
| RDDA | Real-time | ||
| RDDA | Delayed | ||
| RDDA | Delayed | ||
| RDDA | Real-time |
Last Transcript: Dr. Reddy's Laboratories Limited
| 1 day | +0.07% | ||
| 1 week | -1.14% | ||
| Current month | +4.02% | ||
| 1 month | +14.26% | ||
| 3 months | +20.13% | ||
| 6 months | +8.30% | ||
| Current year | +4.99% |
| 1 week | 14.6 | 15.03 | |
| 1 month | 13.02 | 15.08 | |
| Current year | 11.36 | 15.67 | |
| 1 year | 11.36 | 15.67 | |
| 3 years | 11.36 | 16.89 | |
| 5 years | 9.58 | 16.89 | |
| 10 years | 5.63 | 16.89 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 59 | 01/07/2019 |
| Director of Finance/CFO | - | 01/08/2024 | |
Sanjay Sharma
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 13/05/2014 | |
Gunupati Prasad
CHM | Chairman | 65 | 02/04/2013 |
Leo Puri
BRD | Director/Board Member | 65 | 25/10/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.07% | -1.14% | - | - | 1.22TCr | ||
| +1.26% | +6.61% | +40.79% | +145.27% | 1,28600Cr | ||
| +0.79% | +3.45% | +45.84% | +92.04% | 69TCr | ||
| +0.20% | +1.28% | +26.97% | +114.41% | 52TCr | ||
| -0.44% | +3.69% | +41.45% | +70.04% | 39TCr | ||
| +0.55% | +0.70% | +59.02% | +45.79% | 36TCr | ||
| -0.12% | +0.74% | +28.39% | +60.32% | 30TCr | ||
| +0.37% | +0.37% | +3.33% | +38.57% | 29TCr | ||
| -0.30% | +1.14% | +38.29% | +70.56% | 25TCr | ||
| +0.08% | +0.71% | +34.44% | +123.99% | 21TCr | ||
| Average | +0.25% | +2.08% | +35.39% | +84.55% | 48TCr | |
| Weighted average by Cap. | +0.54% | +3.26% | +37.70% | +99.28% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 35TCr 372.56Cr 337.61Cr 312.27Cr 281.75Cr 530.96Cr 549.68Cr 3.75TCr 1.49TCr 19TCr 1.4TCr 1.37TCr 60TCr | 39TCr 416.99Cr 377.87Cr 349.51Cr 315.35Cr 594.28Cr 615.22Cr 4.2TCr 1.66TCr 21TCr 1.56TCr 1.53TCr 67TCr |
| Net income | 3.65TCr 39Cr 35Cr 32Cr 29Cr 55Cr 57Cr 389.75Cr 154.54Cr 1.95TCr 145.26Cr 142.18Cr 6.19TCr | 4.92TCr 52Cr 47Cr 44Cr 39Cr 74Cr 77Cr 525.47Cr 208.36Cr 2.63TCr 195.84Cr 191.69Cr 8.34TCr |
| Net Debt | -3.03TCr -32Cr -29Cr -27Cr -24Cr -46Cr -47Cr -324.02Cr -128.48Cr -1.62TCr -120.77Cr -118.2Cr -5.15TCr | -4.93TCr -52Cr -47Cr -44Cr -40Cr -74Cr -77Cr -525.99Cr -208.57Cr -2.63TCr -196.04Cr -191.88Cr -8.35TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | $14.74 | +0.07% | 37,13,807 |
| 12/26/12 | $14.73 | -0.74% | 16,54,035 |
| 11/26/11 | $14.84 | -0.13% | 21,76,818 |
| 10/26/10 | $14.86 | -1.26% | 17,99,068 |
| 09/26/09 | $15.05 | +0.94% | 25,91,640 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- DRREDDY Stock
- RDY Stock
Select your edition
All financial news and data tailored to specific country editions

















